Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations

NCT04191577 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: CVN424 Low Dose
DRUG: CVN424 High Dose
DRUG: Placebo

Sponsor

Cerevance Beta, Inc.